Skip to content

Chinese auriculoacupuncture to reduce pain and impact on daily activities in elderly women treated in a specialized elderly health unit: randomized clinical trial

Chinese auriculoacupuncture for reducing chronic pain and impact on functional capacity in elderly women treated at the elderly health reference unit (URSI): randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6v29sm4
Enrollment
Unknown
Registered
2024-03-19
Start date
2023-08-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged

Interventions

This is a randomized, single-blind clinical trial. Participants are unaware of the intervention. Intervention group: 40 elderly women with osteoarticular pain in the knee began treatment with auriculo
rim (CO10)
sympathetic nervous system (AH6a)
points for restoring energy balance, and points for the knee (AH64), analgesia (CC129), spleen (CC133) and liver (CC132). This treatment (or intervention) is the standard/routine that patients receive

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Unidade de Referência à Saúde do Idoso
Collaborator

Eligibility

Sex/Gender
Female
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: age from 60 years; presence of chronic osteoarticular pain for 3 months or more, and availability of time for auriculoacupuncture sessions.

Exclusion criteria

Exclusion criteria: presence of infection, inflammation or injury in the ear; allergy to microporous tape; carrying out prior energy therapy up to 3 months prior to the intervention; refusal to receive ear treatment. In addition, the criteria for discontinuing the intervention will be adopted: hospitalization, loss of two consecutive sessions and absence of attendance on the days scheduled for the evaluations.

Design outcomes

Primary

MeasureTime frame
It is expected to find a greater reduction in pain intensity in the intervention group when compared to the control group.

Secondary

MeasureTime frame
No secondary outcomes are expected.

Countries

Brazil

Contacts

Public ContactMeiry Okuno

Universidade Federal de São Paulo

mf.pinto@unifesp.br+55 (11) 5576-4430

Outcome results

None listed

Source: REBEC (via WHO ICTRP)